PROBLEM
BUSINESS
चीन ने विदेशी विक्रेताओं पर शिकंजा कसा, थोक दवा निर्यातकों को लगा झटका
China's enforcement of mandatory inspections for foreign generic drug makers could impose new challenges for India's pharmaceutical industry.
पल्स भारत · क्यों यह अहम है
Livemint पर मूल खबर पढ़ें ↗
The Chinese government's tightening of regulations on overseas generic drug makers poses a significant challenge to India's bulk drug exporters, impacting their business and revenue streams.